Starting Monday, Princeton University will begin administering the first round of a meningitis vaccine to nearly 6,000 of its students.

The vaccine for this particular strain of meningitis has only been licensed for use in Europe and Australia; however, the Food and Drug Administration is allowing for the school to use it for a limited time. Since March, the Ivy League School has been experiencing an outbreak of type B meningococcal disease, in which eight students became ill. Seven university students and one student visitor.

The U.S. Centers for Disease Control and Prevention is recommending all students who live in the dorms to take the vaccine. The first round of the vaccine will be available to students on campus from December 9th, through the 12th. The second dose will not be available until February.